Closed |
SWOG-9507 |
A Single Arm Phase II Study to Determine the Safety and Efficacy of 4-HPR N-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia. |
12/1/1997 |
3/1/2000 |
10% |
|
|
Closed |
SWOG-9509 |
A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Vinorelbine and Cisplatin in Untreated Advanced Non-Small Cell Lung Cancer |
4/1/1996 |
1/1/1998 |
100% |
|
Published
|
Closed |
SWOG-9510 |
Advanced Prostate |
11/1/1996 |
8/15/1999 |
78% |
|
Published
|
Closed |
SWOG-9511 |
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach |
1/15/1997 |
11/15/1998 |
100% |
|
Published
|
Closed |
SWOG-9518 |
Phase II Trial of Continuous Topotecan Infusion in Patients with Advanced Soft Tissue Sarcomas |
4/1/1996 |
10/15/1997 |
55% |
|
Published
|
Closed |
SWOG-9519 |
Evaluation of Tomudex in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
6/15/1996 |
11/1/1997 |
68% |
|
Published
|
Closed |
SWOG-9520 |
Controlled Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer |
12/15/1995 |
10/1/1997 |
100% |
|
Published
|
Closed |
SWOG-9521 |
Evaluation of Nuclear p53 in Patients with Epithelial Ovarian Cancer Patients Registered to SWOG-8835, Ancillary |
3/1/1996 |
11/1/1998 |
|
|
Published
|